Clinical Trial Update: Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China

View source ↗

Summary

Single-center data from China on using letermovir prophylaxis to prevent cytomegalovirus infection in haploidentical hematopoietic stem cell transplant recipien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• PREVYMIS (letermovir)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: CMV Infection, Hematopoietic Stem Cell Transplantation | Status: COMPLETED